Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence

Bone Marrow Transplantation - Tập 37 Số 12 - Trang 1109-1117 - 2006
Shlomit Shalitin1, Moshe Phillip1, Jerry Stein2, Y Goshen2, Doron Carmi1, Isaac Yaniv2
1Institute for Endocrinology and Diabetes, Schneider Children's Medical Center of Israel, Petach Tikva, Israel
2Department of Hematology and Oncology, Bone Marrow Transplantation Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Israel

Tóm tắt

Từ khóa


Tài liệu tham khảo

Shalet SM . Endocrine consequences of treatment of malignant disease. Arch Dis Child 1989; 64: 1635–1641.

Kolb HJ, Bender-Gotze C . Late complications after allogeneic bone marrow transplantation for leukemia. Bone Marrow Transplant 1990; 6: 61–72.

Kashyap A, Kadeel F, Yamauchi D, Palmer JM, Niland JC, Molina A et al. Effects of allogeneic bone marrow transplantation on recipient bone mineral density: a prospective study. Biol Blood Marrow Transplant 2000; 6: 344–351.

Brauner R, Fontoura M, Zucker JM, Devergie A, Souberbielle JC, Prevot-Saucet C et al. Growth and growth hormone secretion after bone marrow transplantation. Arch Dis Child 1993; 68: 458–463.

Legault L, Bonny Y . Endocrine complications of bone marrow transplantation in children. Pediatr Transplant 1999; 3: 60–66.

Toubert ME, Socie G, Gluckman E, Aractingi S, Esperou H, Devergie A et al. Short- and long term follow-up of thyroid dysfunction after allogeneic bone marrow transplantation without the use of preparative total body irradiation. Br J Haematol 1997; 98: 453–457.

Shalet SM, Didi M, Oglivy-Stuart AL, Schulga J, Donaldson MD . Growth and endocrine function after bone marrow transplantation (Review). Clin Endocrinol 1995; 42: 333–339.

Taskinen M, Saarinen-Pinkala UM, Hovi L, Lipsanen-Nyman M . Impaired glucose tolerance and dyslipidemia as late effects after bone-marrow transplantation in childhood. Lancet 2000; 16: 993–997.

Marshall WA, Tanner JM . Variation in the pattern of pubertal changes in girls. Arch Dis Child 1969; 49: 291–303.

Marshall WA, Tanner JM . Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970; 45: 13–23.

Kuczmarski RJ, Ogden CL, Grummer-Strawn LM . CDC Growth Charts: United States Advance Data From Vital and Health Statistics, No. 314. National Center for Health Statistics: Hyattsville, MD, 2000.

Rosenfield R . Puberty in the female and its disorders. In: Sperling MA (ed). Pediatric Endocrinology, 2nd edn. Elsevier Science: Pennsylvania, 2002, p 494.

Styne DM . The testes: disorders of sexual differentiation and puberty in the male. In: Sperling MA (ed). Pediatric Endocrinology, 2nd edn. Elsevier Science: Pennsylvania, 2002, p 599.

Dixon WJ . BMDP Statistical Software. University of California Press: Los Angeles, 1993.

Bakker B, Oostdijk W, Bresters D, Walenkamp MJ, Vossen JM, Wit JM . Disturbances of growth and endocrine function after busulphan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood. Bone Marrow Transplant 2004; 33: 1049–1056.

Cohen A, Rovelli A, Van-Lint MT, Uderzo C, Morchio A, Pezzini C et al. Final height of patients who underwent bone marrow transplantation during childhood. Arch Dis Child 1996; 74: 437–440.

Frisk P, Arvidson J, Gustafsson J, Lonnerholm G . Pubertal development and final height after autologous bone marrow transplantation for acute lymphoblastic leukemia. Bone Marrow Transplant 2004; 33: 205–209.

Giorgiani G, Bozzola M, Locatelli F, Picco P, Zecca M, Cisternino M et al. Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone. Blood 1995; 86: 825–831.

Sanders JE, Pritchard S, Mahoney P, Amos D, Buckner CD, Witherspoon RP et al. Growth and development following marrow transplantation for leukemia. Blood 1986; 68: 1129–1135.

Shankar SM, Bunin NJ, Moshang T . Growth in children undergoing bone marrow transplantation after busulphan and cylophosphamide conditioning. J Pediatr Hematol Oncol 1996; 18: 362–366.

Afify Z, Shaw PJ, Clavano-Harding A, Cowell CT . Growth and endocrine function in children with acute myeloid leukemia after bone marrow transplantation using busulphan/cylophosphamide. Bone Marrow Transplant 2000; 25: 1087–1092.

Thompson RG, Rodriguez A, Kowarski A, Blizzard RM . Growth hormone: metabolic clearance rates, integrated concentrations, and production rates in normal adults and effect of prednisone. J Clin Invest 1972; 51: 3193–3199.

Brauner R, Rappaport R, Prevot C, Czernichow P, Zucker JM, Bataini P et al. A prospective study of the development of growth hormone deficiency in children given cranial irradiation, and its relation to statural growth. J Clin Endocrinol Metab 1989; 68: 346–351.

Ogilvy-Stuart AL, Clark DJ, Wallace WH, Wallace WH, Gibson BE, Stevens RF et al. Endocrine deficit after fractionated total body irradiation. Arch Dis Child 1992; 67: 1107–1110.

Brauner R, Adan L, Souberbielle JC, Esperou H, Michon J, Devergie A et al. Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation. J Pediatr 1997; 130: 785–792.

Katsanis E, Shapiro RS, Robison LL, Haake RJ, Kim T, Pescovitz OH et al. Thyroid dysfunction following bone marrow transplantation: long-term follow-up of 80 pediatric patients. Bone Marrow Transplant 1990; 5: 335–340.

Borgstrom B, Bolme P . Thyroid function in children after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 13: 59–64.

Ishiguro H, Yasuda Y, Tomita Y, Shinagawa T, Shimizu T, Morimoto T et al. Long-term follow-up of thyroid function in patients who received bone marrow transplantation during childhood and adolescence. J Clin Endocrinol Metab 2004; 89: 5981–5986.

Bouland F, Bromley M, Black P, Heller G, Sarafoglou K, Gillio A et al. Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation. Bone Marrow Transplant 1995; 15: 71–76.

Au WY, Lie AK, Kung AW, Liang R, Hawkins BR, Kwong YL . Autoimmune thyroid dysfunction after hematopoietic stem cell transplantation. Bone Marrow Transplant 2005; 35: 383–388.

Sklar C, Whitton J, Mertens A, Stovall M, Green D, Marina N et al. Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivors Study. J Clin Endocrinol Metab 2000; 85: 3227–3232.

Socie G, Curtis RE, Deeg HJ, Sobocinski KA, Filipovich AH, Travis LB et al. New malignant diseases after allogeneic bone marrow transplantation for childhood acute leukemia. J Clin Oncol 2000; 18: 348–357.

Sklar CA, Kim TH, Ramsay NK . Testicular function following bone marrow transplantation performed during or after puberty. Cancer 1984; 53: 1498–1501.

Sarafoglou K, Boulad F, Gillio A, Sklar C . Gonadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr 1997; 130: 210–216.

Sanders JE . The impact of marrow transplant preparative regimens on subsequent growth and development. Semin Hematol 1991; 28: 244–249.

Teinturier C, Hartmann O, Valteau-Couanet D, Benhamou E, Bougneres PF . Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure. Bone Marrow Transplant 1998; 22: 989–994.

Lorini R, Cortona L, Scaramuzza A, De Stefano P, Locatelli F, Bonetti F et al. Hyperinsulinemia in children and adolescents after bone marrow transplantation. Bone Marrow Transplant 1995; 15: 873–877.

Yang JY, Cui XL, He XJ . Non-ketotic hyperosmolar coma complicating steroid treatment in childhood nephrosis. Pediatr Nephrol 1995; 9: 621–626.

Raul Ariza AC, Barile-Fabris LA, Frati-Munari AC, Baltazar- Montufan P . Risk factors for steroid diabetes in rheumatic patients. Arch Med Res 1998; 29: 259–262.

Zein CO, Levy C, Basu A, Zein NN . Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study. Am J Gastroenterol 2005; 100: 48–55.

Kawaguchi T, Nagao Y, Tanaka K, Ide T, Harada M, Kumashiro R et al. Causal relationship between hepatitis C virus core and the development of type 2 diabetes mellitus in a hepatitis C virus hyperendemic area: a pilot study. Int J Mol Med 2005; 16: 109–114.